This is an inflection point and key to FDA approval and commercialization which is what SI will be discussing TODAY at the ISSCR.
Volume will go through the roof today!
- Forums
- ASX - By Stock
- MSB
- Ann: Key Day 100 Survival Results In P3 GvHD Trial
MSB
mesoblast limited
Add to My Watchlist
3.95%
!
$2.37

Ann: Key Day 100 Survival Results In P3 GvHD Trial, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.37 |
Change
0.090(3.95%) |
Mkt cap ! $2.995B |
Open | High | Low | Value | Volume |
$2.31 | $2.39 | $2.30 | $3.963M | 1.689M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 32919 | $2.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.37 | 103860 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 50085 | 2.350 |
27 | 55404 | 2.340 |
21 | 83128 | 2.330 |
16 | 104315 | 2.320 |
10 | 78565 | 2.310 |
Price($) | Vol. | No. |
---|---|---|
2.360 | 4744 | 4 |
2.370 | 105759 | 21 |
2.380 | 318935 | 21 |
2.390 | 90362 | 17 |
2.400 | 459055 | 27 |
Last trade - 10.51am 23/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |